Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Locations section reorganized; a unified 'Locations' header was added and state-level site entries updated (Arizona, California, Colorado, Kentucky, Michigan, Minnesota, Nebraska, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Wisconsin).
    Difference
    1%
    Check dated 2025-12-17T20:18:20.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:51:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding and NIH Clinical Center operating status was removed, a non-significant site-wide change; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:33:26.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    No core study content changes are evident; the screenshots show only minor UI/layout differences on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:15:05.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Major changes include a government operating status notice update and a version bump from v3.1.0 to v3.2.0. The status notice is the most important element; the version change is secondary.
    Difference
    4%
    Check dated 2025-10-06T16:09:32.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T10:10:58.000Z thumbnail image

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.